<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03096639</url>
  </required_header>
  <id_info>
    <org_study_id>P-200</org_study_id>
    <nct_id>NCT03096639</nct_id>
  </id_info>
  <brief_title>Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing</brief_title>
  <acronym>RESCUE2</acronym>
  <official_title>Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lungpacer Medical Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Syntactx</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lungpacer Medical Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized clinical trial to investigate the use of the temporary Diaphragm Pacing Therapy
      System (DPTS) to rehabilitate the diaphragm in mechanically ventilated patients who have
      failed at least two weaning attempts. The goal is to strengthen and rehabilitate the
      diaphragm to liberate the patient more quickly from mechanical ventilation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mechanical ventilation (MV) is a life saving technology but can also cause damage to the
      lungs and diaphragm such as ventricular induced diaphragmatic dysfunction (VIDD). Research
      has shown that after being on mandatory MV and sedated the diaphragm begins to atrophy within
      as short as 18 hours. The Lungpacer Diaphragm Pacing Therapy System (DPTS) is a temporary
      therapy that consists of the Lungpacer IntraVenous Electrode Catheter (LIVE Catheter) and the
      Lungpacer Control Unit system. The LIVE Catheter is a proprietary central venous catheter
      that incorporates pacing electrodes in strategic areas that align with the left and right
      phrenic nerves. The LIVE Catheter can also be used for fluid delivery like any other central
      venous catheter. The randomized clinical trial will investigate the safety, effectiveness and
      performance of the Lungpacer DPTS. By stimulating the diaphragm through daily therapy
      sessions, with the intention of exercising and rehabilitating the diaphragm muscle so the
      patient may be able to be more quickly liberated from MV. The patient population includes
      those who have been mechanically ventilated for greater than or equal to 7 days, have failed
      two or more spontaneous breathing trials (SBT), and were not hypervolemic during the latest
      spontaneous breathing trial. Patients must have resolution of the initial indication for
      placement on mechanical ventilation before entering the trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 20, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1 randomization of treatment and control group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The ultrasound core lab reviewers will be blinded to patient information, study dates and times of study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Successful Extubation with No Reintubation within 48 hours</measure>
    <time_frame>Patients will be allowed to stay in the study for up to 30 days if not extubated sooner.</time_frame>
    <description>Removal from mechanical ventilation for greater than or equal to 48 hours during the study duration of 30 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to reintubation if applicable</measure>
    <time_frame>from randomization to 30 days</time_frame>
    <description>time placed back on mechanical ventilation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Ventilator Induced Diaphragm Dysfunction</condition>
  <arm_group>
    <arm_group_label>Diaphragm Pacing Therapy DPTS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diaphragm Pacing intervention will be conducted 3x a day using the Diaphragmatic Pacing Therapy System (DPTS). The DPTS includes the Lungpacer IntraVenous Electrode Catheter (LIVE Catheter) which is inserted temporarily into the left subclavian vein, the Lungpacer Control Unit (LCU external unit) and an intermediate cable that connects the LCU to the LIVE Catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care treatment of weaning failure, no intervention is involved in this control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Diaphragmatic Pacing Therapy DPTS</intervention_name>
    <description>Subjects will undergo DPTS 3 times a day until successfully extubated with no reintubation within 48 hours.</description>
    <arm_group_label>Diaphragm Pacing Therapy DPTS</arm_group_label>
    <other_name>DPTS</other_name>
    <other_name>LIVE Catheter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  have been mechanically ventilated for &gt; or = 7 days and have not met criteria for
             successful weaning during this period, and

          -  have failed at least two SBTs, one of which is the study specific SBT (self extubation
             with subsequent reintubation within 48 hours is considered a failed SBT).

        Exclusion Criteria:

          -  currently on extracorporeal membrane oxygenation (ECMO);

          -  weaning failure due to hypervolemia;

          -  known anatomy that prevents insertion of the LIVE Catheter into the left subclavian
             vein;

          -  history of congenital heart disease;

          -  clinically overt congestive heart failure;

          -  pre-existing neuromuscular diseases that could affect the respiratory muscles;

          -  pleural effusions occupying greater than one third of the pleural space on either
             side;

          -  BMI &gt; or = 40;

          -  known or suspected phrenic nerve paralysis;

          -  any electrical device (implanted or external) that may be prone to interaction with or
             interference from the Lungpacer DPTS including neurological pacing/stimulator devices,
             cardiac pacemakers and defibrillators;

          -  bacteremia (blood cultures must be negative for 48 hours);

          -  current haemodynamic instability, shock or severe sepsis;

          -  terminally ill with 6 months or less life expectancy or not committed to full care;
             and

          -  known or suspected to be pregnant or lactating.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linda H Clark, BSN</last_name>
    <role>Study Director</role>
    <affiliation>Global Director of Clinical Affairs, Lungpacer Medical, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Linda H Clark, BSN</last_name>
    <phone>512-633-7077</phone>
    <email>lclark@lungpacer.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kai Maertens</last_name>
    <email>kmaertens@lungpacer.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Angers, Reanimation Medicale</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <email>LaMasson@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Alain Mercat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Asfar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Satar Mortaza, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francois Beloncle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Yves Olivier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Achille Kouatchet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc Pierrot, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de la Croix Rousse, Reanimation Medicale</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>PI</last_name>
      <email>claude.guerin@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Claude Guerin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pitie Salpetriere Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study manager, PhD</last_name>
      <email>sophie.lavault@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Martin Dres, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander Demoule, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Similowski, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie Delemazure</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uniklinik RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator, M.Sc.</last_name>
      <email>ehristodorova@ukaachen.de</email>
    </contact>
    <investigator>
      <last_name>Christian Brulls, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andreas Goetzenich, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Breuer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heart and Diabetes Center Bad Oeynhausen</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <email>SSiegling@hdz-nrw.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Bitter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Henrick Fox, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Flottmann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olaf Oldenburg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lisa-Katharina Wolf, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hazem Omran, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charite Universitatsmedizin Berlin - Mitte campus</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Holger Muller-Redetzky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander Uhrig, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <email>ute.Lohmer@ukbonn.de</email>
    </contact>
    <investigator>
      <last_name>Christian Putensen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Muders, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jens Schewe, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Scholz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nils Theuerkauf, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carsten Weissbrich, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinik Dresden</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>PI, Prof. Dr. Med</last_name>
      <email>mgabreu@uniklinijum-dresden.de</email>
    </contact>
    <investigator>
      <last_name>Marcelo G Abreu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andreas Guldner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Ullig, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Spieth, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsmedizin Gottingen, Georg-August-Universitat</name>
      <address>
        <city>Gottingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <email>akernch@gwdg.de</email>
    </contact>
    <investigator>
      <last_name>Onnen MÃ¶rer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Quintel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lars-Olav Harnisch, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2017</study_first_submitted>
  <study_first_submitted_qc>March 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2017</study_first_posted>
  <last_update_submitted>September 20, 2017</last_update_submitted>
  <last_update_submitted_qc>September 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diaphragm atrophy</keyword>
  <keyword>VIDD</keyword>
  <keyword>Weaning failure</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Only investigators participating in this clinical trial will be able to see final de-identified participant data at the completion of the study and it will be available through the clinical research organization (CRO).</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

